Market Access Program

In recent years BFC developed a EU-Market Access Program to support pharmaceutical companies with the marketing of pharmaceutical products. It includes all necessary elements for the launch of a pharmaceutical product on the Dutch or European market. These elements can consist of:

  • Marketing authorization approval process
  • Supply chain support and distribution strategy
  • Additional licensing activities e.g. for opioid distribution
  • Pricing & reimbursement applications
  • Promotion and advertising compliance monitoring
  • Pharmacovigilance systems including interfacing with EudraVigilance
  • Post-Approval Committment implementations

In particular foreign companies, new to the Dutch pharmaceutical environment, may benefit significantly from such a program which will be tailored to the needs of the product and its company.